Longevity Research Compounds: Telomerase Activation and Cellular Senescence

Longevity research compounds target the molecular mechanisms of cellular aging — telomere maintenance, senescent cell accumulation, and age-related signaling pathway decline. AUREX offers two longevity-focused compounds: AX-05 (Longevity I) targeting telomerase activation and AX-06 (Longevity II) targeting copper-peptide mediated tissue renewal.

AX-05 (Longevity I) — Telomerase Activation: AX-05 is under active investigation in cellular senescence research. Published preclinical data demonstrates pineal-mediated modulation of circadian gene expression, melatonin synthesis restoration, and telomere elongation in dividing cell populations. The compound's mechanism centers on activation of telomerase reverse transcriptase (hTERT), the catalytic subunit responsible for adding TTAGGG repeats to chromosome ends during cell division.

AX-05 Research Applications: Published preclinical models report measurable telomere elongation in lymphocyte populations after 3-6 month protocols, restoration of age-declining melatonin secretion patterns, improved T-cell proliferative capacity (immune reconstitution), enhanced antioxidant enzyme expression (SOD, catalase, glutathione peroxidase), and modulation of age-related gene expression profiles toward younger phenotypes. AX-05 is priced at $79.99 for 10mg with ≥99% purity.

AX-06 (Longevity II) — Copper-Peptide Signaling: AX-06 operates through GHK-copper complex formation, a naturally occurring tripeptide-metal complex whose endogenous levels decline significantly with age (60%+ reduction by age 60 in published human data). The copper-peptide complex activates tissue remodeling pathways including collagen synthesis, glycosaminoglycan production, and metalloproteinase regulation. Research models demonstrate broad regenerative signaling across skin, lung, bone, and nervous tissue.

AX-06 Research Applications: Published data demonstrates accelerated wound healing through enhanced collagen I/III ratio normalization, improved skin thickness and elasticity markers in aging models, enhanced nerve growth factor expression, anti-inflammatory activity through suppression of pro-fibrotic cytokines (TGF-beta modulation), and activation of DNA repair enzyme expression. The compound's multi-tissue regenerative profile makes it one of the most versatile compounds in longevity research.

Combination Longevity Protocols: The AUREX PRO-02 (Performance Stack) and research groups investigating combined longevity protocols report complementary mechanisms — AX-05 addresses replicative senescence at the chromosomal level while AX-06 targets functional tissue decline through copper-dependent regenerative signaling. These represent orthogonal approaches to age-related deterioration.

All AUREX longevity compounds are synthesized in cGMP-compliant US facilities, independently verified at ≥98.5-99% purity by third-party HPLC-MS, and shipped same-day with cold-chain packaging.